Anti-viral agents: potential utility in exacerbations of asthma
- PMID: 23664758
- PMCID: PMC7172264
- DOI: 10.1016/j.coph.2013.04.010
Anti-viral agents: potential utility in exacerbations of asthma
Abstract
Asthma is the most common chronic respiratory disease and its prevalence is on the increase. Respiratory viral infections in early life have been suggested to increase the risk of development of asthma in later life and virus infection remains the single greatest precipitant of asthma exacerbations. The development of effective anti-viral treatments remains a key target for therapeutic intervention. Here we discuss the role of respiratory viral infection in asthma exacerbation and highlight current and potential anti-viral agents and their mechanisms of action.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.
Figures
References
-
- Masoli M., Fabian D., Holt S., Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59:469–478. - PubMed
-
- Ivanova J.I. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Allergy Clin Immunol. 2012;129:1229–1235. - PubMed
-
Study comparing direct health care costs between moderate/severe asthmatics with and without exacerbations. Demonstrated that moderate severe asthmatics who had exacerbations had higher total and asthma related health care costs.
-
- Corne J.M. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet. 2002;359:831–834. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
